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Abstract
Background: Blastocystis is a genetically diverse and a common intestinal parasite of humans with a controversial
pathogenic potential. This study was carried out to identify the Blastocystis subtypes and their association with
demographic and socioeconomic factors among outpatients living in Sebha city, Libya.
Methods/Findings: Blastocystis in stool samples were cultured followed by isolation, PCR amplification of a partial
SSU rDNA gene, cloning, and sequencing. The DNA sequences of isolated clones showed 98.3% to 100% identity
with the reference Blastocystis isolates from the Genbank. Multiple sequence alignment showed polymorphism from
one to seven base substitution and/or insertion/deletion in several groups of non-identical nucleotides clones.
Phylogenetic analysis revealed three assemblage subtypes (ST) with ST1 as the most prevalent (51.1%) followed by
ST2 (24.4%), ST3 (17.8%) and mixed infections of two concurrent subtypes (6.7%).
Blastocystis: ST1 infection was significantly associated with female (P = 0.009) and low educational level (P =
0.034). ST2 was also significantly associated with low educational level (P= 0.008) and ST3 with diarrhoea (P =
0.008).
Conclusion: Phylogenetic analysis of Libyan Blastocystis isolates identified three different subtypes; with ST1 being
the predominant subtype and its infection was significantly associated with female gender and low educational level.
More extensive studies are needed in order to relate each Blastocystis subtype with clinical symptoms and potential
transmission sources in this community.
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Introduction
Blastocystis hominis is an enteric unicellular parasite of
humans and many animals. It is classified taxonomically within
the heterogeneous group of the Stramenopiles [1]. Blastocystis
infections have a worldwide distribution with prevalence of 30%
to 60% in developing countries and 1.5% to 20% in developed
countries [2,3]. These differences are due to poor hygiene
practices and consumption of contaminated food or water
[2,4,5]. The organism is mainly transmitted through the faecal-
oral route [6]. A higher risk of infection has been found in
humans with close animal contact and several studies provided
molecular-based evidence on the zoonotic potential of
Blastocystis sp. [7,8,9,10]. Blastocystis is currently classified
into 17 small subunit ribosomal RNA (SSU rDNA) subtypes
(STs; ST1–17) according to the nomenclature established by
Stensvold et al. [11]. These subtypes represent genetically
diverse Blastocystis species isolated from humans and
animals. A majority of human infections with Blastocystis sp.
are attributable to ST3, but infections with ST1, ST2 and ST4
are also common [12,13]. ST5-ST9 have been isolated only
sporadically from humans [9,14,15] while ST10–ST17 have not
been found in humans to date [8,16,17,18,19].
The pathogenic potential of Blastocystis is controversial
because the infection can be asymptomatic. However,
accumulating epidemiological data strongly suggest that
Blastocystis is an emerging pathogen [20]. The controversial
pathogenesis of Blastocystis may attribute to subtype
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variations in virulence thus explaining the variability in
symptoms observed in Blastocystis patients. Several recent
reports suggested that ST1, ST4, and ST7 were pathogenic
[21,22,23] whereas ST2 and ST3 consist of both pathogenic
and non-pathogenic parasites [24,25]. Infection with
Blastocystis is believed to be associated with gastrointestinal
symptoms including acute or chronic diarrhoea, abdominal
pain, flatulence, anorexia, nausea and vomiting [26,27,28].
Beside, this parasite may also play a significant role in several
chronic gastrointestinal illnesses such as irritable bowel
syndrome and inflammatory bowel disease [29,30,31]. In Libya,
studies on Blastocystis are limited and most of available data
pertaining to human Blastocystis were derived from direct
faecal smear examination [32,33,34,35]. Therefore, this study
represents the first investigation of Blastocystis subtypes and
its associated factors in Libyan outpatients.
Materials and Methods
Ethics statement and patient record
The protocol of this study was approved by the Medical
Ethics Committee of University Malaya Medical Centre (MEC
Ref. No: 782.11), Kuala Lumpur, Malaysia. Permission to
conduct this study was also given by the Faculty of Engineering
and Technology, University of Sebha and Sebha Central
laboratory authorities (Ref. No: 533/2010). Prior to data
collection, the objectives, the possible advantages and
disadvantages of this study were explained to the participants.
After a clear explanation, a written consent was then obtained
from each of volunteer, as well as from parents or guardians on
behalf of their children. Each volunteer was then given a 100
mL volume wide-mounted and spoon-screw-capped container,
in which to put a faecal specimen and bring to the Sebha
Central laboratory. Only volunteers who gave their consents
and were able to provide fresh stool specimens were included
in the study. Upon receiving the stool specimens, patient’s
personal information and complaints were collected using a
standardized questionnaire. On the basis of patient records,
Blastocystis-positive individuals were characterized as
‘asymptomatic’ without any gastrointestinal (GI) symptoms or
‘symptomatic’ with GI symptoms including abdominal pain,
diarrhoea (≥3 loose or watery stools per day), flatulence,
constipation, nausea and vomiting. Data collection and analysis
of faecal specimens were carried out between August and
November 2010.
Collection of stool samples and cultivation of
Blastocystis
This cross-sectional study was carried out in Sebha city,
about 800 km south of Tripoli (longitude 14.42°E, latitude
27.03°N), Libya. The area is characterized by desert climate,
dry and hot weather and low rainfall. Agriculture is the main
occupation of the people and underground wells are the main
source of water for drinking and household use. Detailed
description of the study area and population has been
published previously [36]. Stool samples were obtained from
symptomatic and asymptomatic individuals of outpatients
visiting the Sebha Central Laboratory. Screening for
Blastocystis and other intestinal parasites was performed
immediately upon receiving the stool specimens by using direct
smear preparation, xenic in vitro culture (XIVC), formalin ethyl
acetate concentration, trichrome stain and modified Ziehl-
Neelsen stain. Investigation on the potential viral or bacterial
infection was not carried out in this study.
The xenic in vitro culture (XIVC) is used as a standard
method for diagnosis of Blastocytis in Para :SEAD Laboratory
(a diagnostic division of the Department of Parasitology,
University Malaya Medical Centre, Malaysia) for more than 15
years. Recently, XIVC has been reported to be more sensitive
in detecting Blastocystis although it is not commonly used in
the diagnostic laboratory [37,38,39]. For each culture,
approximately 50 mg of stool was inoculated into a 15-mL
screw-cap tube containing 5 mL of Jones’ medium
supplemented with 10% horse serum. Four replicates of
inoculation were carried out for each stool sample. All
inoculated tubes were tightly-closed, placed in a rack and
incubated at 37°C for 2-3 days. The presence of Blastocystis
sp. was observed daily for 14 days of cultivation, by placing
one drop of the cultured sediment onto a glass slide, covered
with a cover slip and viewed (X100 and X400 objectives) under
light microscopy. Positive cultures were defined by the
detection of any form of Blastocystis sp. (i.e. vacuolar, granular
and amoeboid forms). Positive cultures were subsequently
sub-cultured into fresh complete Jones medium once every two
days. Each of Blastocystis positive XIVC was packaged
approximately 1-2 x 104 cells in 10 ml of complete Jones’
medium, in a tightly closed culture tubes and shipped to
Malaysia by air.
DNA extraction
Blastocystis cells were sub-cultured in the laboratory of the
Department of Parasitology, University Malaya Medical Centre,
Malaysia. Approximate 1×106 Blastocystis cells were harvested
from cultures by centrifugation at 500×g for 5 min. The pellet
was washed with phosphate-buffered saline (pH 7.4) for five
times using centrifugation. The clean cells were subjected to
extraction of genomic DNA with the DNAzol® Reagent
(Invitrogen, USA) following the manufacturer’s instructions.
PCR amplification
For each sample, 2-5 μL (20 ng/μL) genomic DNA was
subjected to PCR analysis using the forward Blast 505–532 (5’
GGA GGT AGT GAC AAT AAATC 3’) [40] and reverse Blast
998–1017 (5’TGC TTT CGC ACT TGT TCATC 3’) [41] primers,
targeting the small subunit (SSU) rDNA gene of Blastocystis.
PCR amplification was performed in a 50-μL volume per
reaction using 1 μM of each primer (Bioneer, South Korea), 1×
PCR buffer, 1.5 mM MgCl2, 0.2 mM dNTP, 2.5 U Taq
(Fermentas) and 2.5 μL BSA (0.1 g/10 mL) (New England
Biolabs, USA). The PCR amplification consisted of 35 cycles of
95°C for 30 sec, 54°C for 30 sec and 72°C for 30 sec after an
initial pre-heat step at 95°C for 4 min. A final extension step at
72°C for 5 min was included [41]. The PCR products were
separated by agarose gel electrophoresis, and bands of the
expected size (approximately 500 bp) were purified using the
Blastocystis Subtypes in Libyan Outpatients
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QIAgen Gel Extraction Kit (QIAGEN, USA) according to the
manufacturer’s protocol.
Cloning and sequencing
Purified PCR products were cloned in the pGEM®-T Vector
(Promega, USA) and amplified in Escherichia coli JM109
competent cells. Recombinant clones were selected from each
specimen and screened by PCR. Minipreparations of plasmid
DNA were done using the QIAprep Spin Miniprep kit (QIAGEN,
USA). Three or four clones containing inserts of approximately
the expected size were arbitrarily selected for each sample and
sequenced on both strands using M13 forward (5’GTA AAA
CGA CGG CCA GT 3’) and reverse (5’GCG GAT AAC AAT
TTC ACA CAG G 3’) primers. Cycle sequencing was carried
out using the ABI BigDye® Terminator Cycle Sequencing
Ready Reaction Kit v3.1, using the ABI PRISM® 3730xl DNA
Analyzer (Applied Biosystems, USA). Sequences obtained in
this study have been deposited in Genbank under accession
numbers KF306282 to KF306295.
Phylogenetic analysis
Chromatogram sequences belonging to cloned DNA
fragment were extracted from the vector using Gene Runner
software (version 3.05). These sequences were then subjected
to BLAST searches in the Genbank database to confirm
isolates as Blastocystis sp. The subtypes were identified by
determining the exact match or closest similarity against all
known Blastocystis subtypes according to the last classification
by Stensvold et al. [11]. The published sequences from
Genbank and those obtained from this study were aligned
using Clustal W property implemented in BioEdit software
(version 7.0.9.0) [42]. The phylogenetic tree was then
constructed with neighbor-joining (NJ) analysis of SSU rDNA
using the MEGA version 4 software [43], and molecular
distances were estimated by Kimura two-parameter model [44].
Branch reliability was assessed using bootstrap analysis (1000
replicates). Proteromonas lacerate (U37108) was used as the
out-group.
Statistical analysis
Statistical analysis was performed using the Statistical
Package for Social Sciences for Windows (SPSS), version11.5
(SPSS Inc, Chicago, IL, USA). Pearson’s Chi-square (χ2) or
Fisher’s exact test was used where appropriate to test the
associations between Blastocystis subtypes and associated
factors. All P values < 0.05 were considered statistically
significant.
Results
Description of test isolates
A total of 380 stool samples were collected from the Libyan
outpatients, which consisted of 197 males and 183 females,
aged from 1 to 75 years (median age = 25 years, inter-quartile
range = 36 years). Blastocystis was detected in 84 (22.1%)
samples by using microscopy after in vitro cultivation. On
analysis, 54 and 30 of these samples were from symptomatic
(abdominal pain, flatulence diarrhoea, constipation, nausea
and vomiting) and asymptomatic patients, respectively. The
general characteristics of the outpatients are shown in Table
S1.
Only 64 samples were subjected for PCR amplification as
the remaining (20/84) died off during subsequent sub-cultures.
Out of the 64 isolates, 86.0% (55/64) successfully produced the
expected size of 500 bp fragment of the SSU rDNA after PCR
amplification. Of these, 45 isolates were successfully cloned in
Escherichia coli JM109 and readable DNA sequences were
obtained at approximately 479-483 bp of the Blastocystis SSU
rDNA gene. After the BLAST search, all of these isolate clones
sequences showed a high homology (98.3-100%) with their
closest matching reference sequences of Blastocystis from
Genbank. Concurrently, these 45 isolates were from 45
patient’s stool samples, of which 43 were detected only
Blastocystis and 2 (L5-27/M and L18-9/F) were co-infected with
Cryptosporidium and Giardia intestinalis, respectively (Table
S2).
Phylogenetic analysis and multiple alignments
The isolate clones sequences were detected to be clustered
under three respective subtypes after phylogenetic analysis
with the selected reference isolates of Blastocystis assemblage
subtypes ST1 to ST9 (Table 1). Phylogenetic tree was
constructed using the stramenopile Proteromonas lacerate as
the out-group (Figure 1). The rooted neighbor-joining tree
identified nine clades that corresponded to ST to ST9, and
each subtype was shown strongly supported by high bootstrap
values. The clones that were grouped in the same subtype
clustered with each other with good bootstrap support, and
therefore the three respective subtypes (ST1, ST2, and ST3)
were seen as three independent monophyletic groups. ST1,
ST2 and ST3 formed a group of the triplicate clone (a,b,c)
sequences with identical nucleotides representing 19, 10 and 7
isolates, respectively (Table S2). The other 9 isolates consisted
of clones sequences with non-identical nucleotides belonging
to either the same or different Blastocystis subtypes. In
general, 42 isolates were of a single subtype, where 23, 11,
and 8 were under ST1, ST2 and ST3, respectively. Another 3
isolates were detected to be a mix of two different subtypes;
one (LMS-29) consists of ST1 and ST3, and the other two
(LM-44, LF-45) consist of ST1 and ST2, respectively (Table
S2).
Multiple pair-wise alignments of DNA sequences among
isolate clones were performed against the SSU rDNA gene of
their closest match reference strains from Genbank
represented by Blastocystis ST1, ST2 and ST3. The DNA
sequences of isolate clones that showed 100% homology with
their closest match reference were only seen in ST1 and ST3.
However, up to seven bases polymorphism due to base
insertion, substitution and deletion were seen in all isolate
clones belonging to ST2; six groups of clones [(LMS-5cd)
(LFS-6a,b, LM-35a,c, LMS-29a,b) (LM-33c,d) (LFS-6c,d, LM-35b,d)
(LF-45a,b, LM-44a,b) (LMS-29ab)] belonging to ST1 and two
groups [(LMS-26ab) (LMS-29cd)] belonging to ST3 (Table S2
and Table 2).
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Designation: Clone (a,b,c,d), base insertion (BI), base
substitution (BS), base deletion (BD), subtype of Blastocystis
(ST), Blastocystis isolate from Libyan female (LF), female with
Table 1. Genbank reference sequence of Blastocystis
isolates used in the construction of phylogenetic tree.
Subtype Accession number Host Reference
ST1 AB070989 Human [48]
 AB107967 Monkey [70]
 EU445488 Monkey [71]
ST2 AB070997 Monkey [48]
 AB107969 Monkey [70]
ST3 AM779042 Human [12]
 AB107963 Pig [70]
 EU445494 Human [71]
ST4 AB071000 Rat [48]
 AY590111 Rat [7]
ST5 AB070998 Pig [48]
 AB070999 Pig [48]
ST6 AB107972 Bird [70]
 AB070990 Human [48]
ST7 AB070991 Human [48]
 AB107973 Bird [70]
ST8 AB107970 Primate [70]
ST9 AF408426 Human [55]
doi: 10.1371/journal.pone.0084372.t001
symptom (LFS), male (LM), male with symptom (LMS),
guanine (G), cytosine (C), adenine (A), thymine (T), base
deletion/insertion position (-). Sequence of isolate clones (bold
font) and the reference isolates (accession number) were used
in the phylogenetic analysis.
Subtype and related factors
Blastocystis ST1 was the most prevalent among Libyan
outpatients (51.1%, 23/45), followed by ST2 (24.4%, 11/45)
and ST3 (17.8%, 8/45). In addition, 6.7% (3/45) were mixed
infections consisting of two subtypes, which are either ST1 and
ST2 or ST1 and ST3. Concurrently, ST1 and ST2 were
detected in both asymptomatic and symptomatic patients,
whereas all patients with ST3 presented with gastrointestinal
symptoms (Table S2). The association between Blastocystis
ST1, ST2 and ST3 infections and some demographic and
socioeconomic factors was appropriately analysed either by
Chi-square test or Fisher’s exact test and the results are
presented in Table 3. Blastocystis ST1 infection was
significantly associated with the female gender (x2 = 6.736; P =
0.009) and low educational level (x2 = 4.325; P = 0.034).
Infection with Blastocystis ST2 was significantly associated
with low educational level (Fisher’s exact test; P = 0.008). ST3
was significantly associated with diarrhoea (Fisher’s exact test;
P = 0.008). No significant associations were found between
infections with any of the observed Blastocystis subtypes and
age group, working status, drinking water (treated or untreated)
or the presence of animal in the household.
Table 2. Heterogeneity of Blastocystis clone against selected closest match reference from Genbank.
Isolate (clones) from symptomatic and asymptomatic Sequence BI BS BD No. of ST Reference isolate
patients homology    BI/BS/BD  (Accession no.)
LFS-1 (a,b,c) (other 20 isolate clones stated in Table S2) 100%     1 MJ99-424 (AB107967);
LMS-5 (c,d) 99.7%  G280 →C  1BS  J96A-29, (AB070989)
LM-33 (c,d) 99.7%  G280 →A  1BS   
LM-44 (a,b), LF-45 (a,b) 99.7%  C36→A  1BS   
LMS-29 (a,b) 98.9% - 194→T  C188→ - 1BI, 1BD   
LMS-18 (a,b,c), LM-19 (a,b,c), LFS-20 (a,b,c), 98.9% -199→C T208→C T193→ - 2BI, 1BS,2BD   
LM-40 (a,b,c), LF-41 (a,b,c), LM-42 (a,d)  - 200→C  T 216→ -    
LFS-6 (a,b), LM-35 (a,c) 98.7% - 193→C  C188 → - 1BI, 1BD   
LM-42 (b,c) 98.7% -199→C T208→C T193→ - 2BI, 2BS,2BD   
  - 200→C C230→T T 216→ -    
LFS-6 (c,d), LM-35 (b,d) 98.5% - 193→C T209→A C188→ - 1BI, 1BS,1BD   
LMS-16 (a,b,c), LMS-17 (a,b,c), LM-39 (a,b,c) 99.7%  T207→C  1BS 2 MJ99-116(AB107969)
LM-43 (a,b,c)        
LM-44 (c,d), LF-45 (c,d) 98.3% - 198→T T36→C T193→ - 2BI, 3BS,2BD   
  - 200 →G T208→C T 216→ -    
   A467→G     
LMS-21 (a,b,c) (other 7 isolate clones stated in Table S2) 100%     3 PJ99-162(AB107963)
LMS-29 (c,d) 99.7%  A222→T  1BS   
LMS-26 (a,b) 99.1%  G214→T  4BS   
   T215→G     
   C220→A     
   T274→A     
doi: 10.1371/journal.pone.0084372.t002
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Discussion
In the present study, the overall prevalence of Blastocystis
was 22.1% (84/380). Of these, 64 isolates were subjected to
PCR amplification and in 86.0% (55/64) the expected 500 bp
fragment of the SSU rDNA was successfully amplified. In 9
instances, no PCR product was produced despite repeated
DNA extractions and several attempts towards optimising PCR
conditions. Possible reasons for this could be due to PCR
inhibition. A previous molecular study found that PCR failed to
detect 25% of samples that were positive by culture due to
PCR inhibitors in stool samples [13]. It is also possible that this
specimen contained an isolate not amplifiable by the primers
[45]. Indeed, the choice of PCR primers may influence the
ability to successfully detect the parasite with the possibility
that some primers are more subtype-specific. Furthermore,
some primers work well with cultured isolates, whereas others
work well with DNA extracted directly from faeces. Because of
Figure 1.  Phylogenetic tree of the SSU-rDNA gene
sequences of Blastocystis isolates as inferred using the
neighbour-joining method.  Isolate or strain names are as
provided in Genbank as available, followed by accession
numbers in parentheses. Sequences generated in this study
(designated ‘LM(S), LF(S)’ followed by clones ‘a,b,c,d’) are in red
font. Proteromonas lacerate (accession number U37108)
served as the out-group. Bootstrap values (%) are indicated at
the internal nodes (1,000 replicates). Bootstrap values of less
than 50% are not shown.
doi: 10.1371/journal.pone.0084372.g001
the possibility that not all Blastocystis STs have been identified,
it is advisable to use multiple primer pairs, or to develop
multiplex PCR analyses for characterizing Blastocystis isolates
[46]. Of 55 PCR-positive samples, 45 isolates were
successfully cloned and readable DNA sequences were
obtained. For the other 10 PCR positive isolates (10/55), the
Table 3. Association between Blastocystis subtypes and
related potential factors.
Variable ST1 ST2 ST3
 
Frequency
(%) P a
Frequency
(%) P b
Frequency
(%) P b
Gender  0.009 *  0.080  0.431
Female 14 (60.9)  3 (27.3)  2 (25.0)  
Male 9 (39.1)  8 (72.7)  6 (75.0)  
Age  0.056  0.123  NA
≥18 years 18 (78.3)  9 (81.8)  8 (100.0)  
<18 years 5 (21.7)  2 (18.2)  0 (0.00)  
Education level  0.034*  0.008*  0.932
Low (≤ Primary
school) 18 (78.3)  9 (81.8)  5 (62.5)  
High
(≥Secondary
school)
5 (21.7)  2 (18.2)  3 (37.5)  
Occupational
status  0.801  0.987  0.764
Not working 13 (56.5)  6 (54.5)  4 (50.0)  
Working 10 (43.5)  5 (45.5)  4 (50.0)  
Family size  0.711  0.974  0.709
≥ 7 members
(large) 12 (52.2)  6 (54.5)  5 (62.5)  
< 7 members
(small) 11 (47.8)  5 (45.5)  3 (37.5)  
Presence of
animals in the
house
 0.488  0.353  0.725
Yes 10 (43.5)  7 (63.6)  3 (37.5)  
No 13 (56.5)  4 (36.4)  5 (62.5)  
Drinking water  0.204  0.867  0.243
Untreated 13 (56.5)  5 (45.5)  4 (50.0)  
Treated
(chlorinated,
filtered or
boiled)
10 (43.5)  6 (54.5)  4 (50.0)  
Diarrhoea  0.480  0.303  0.008*
Yes 8 (34.8)  4 (36.4)  7 (87.5)  
No 15 (65.2)  7 (63.6)  1 (12.5)  
Abdominal pain  0.384  0.384  0.700
Yes 10 (43.5)  6 (54.5)  4 (50.0)  
No 13 (56.5)  5 (45.5)  4 (50.0)  
Flatulence  0.270  0.270  0.686
Yes 7 (30.4)  5 (45.5)  3 (37.5)  
No 16 (69.6)  6 (54.5)  5 (62.5)  
a Chi square test, bFisher’s Exact test, *Significant association (P<0.05), not
applicable (NA).
doi: 10.1371/journal.pone.0084372.t003
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recombinant clones could not be obtained despite numerous
attempts toward optimizing the cloning reaction. This could be
due to the presence of an inhibitory component in the PCR
product or damage to the DNA caused by UV light during
excision from the agarose gel. Thus, preparing a new DNA
template was necessary; however, this was not done for these
samples as it was not possible to collect new samples from
related patients.
There was no nucleotide differences found among the 36 out
of 45 Blastocystis isolates. In 9 instances, nucleotide
differences were detected among the three groups of clones.
Of these, 3 isolates (LMS-29, LM-44 and LF-45) from each
L27-45/M, L3-20/M and L4-33/F patient were mixed infections
containing two different Blastocystis subtypes. The difference
between the two groups of duplicate clones in the similar
isolate is likely due to the co-infection with two variants within
the same subtype or sequence variations between SSU rDNA
gene copies within the same isolate [47]. The sequence
heterogeneity (intra- and inter-subtype) of the SSU rDNA
genes among Blastocystis isolates were reported in many
previous studies [7,48,49,50].
The DNA sequences of isolate clones assemblage
Blastocystis ST1 revealed 98.5% to 100% identity with the
reference Blastocystis isolate MJ99-424 (AB107967) and
HJ96A-29 (AB070989). Intra-subtype sequence polymorphism
was due to a single base substitution, an insertion, or a
deletion. For ST2, all isolate clones showed nucleotide
polymorphism (98.3 - 99.7% homology) in comparison with the
reference isolate MJ99-116 (AB107969), with up to 3 base
substitutions, 2 insertions and 2 deletions. Subsequently,
isolate clones assemblage ST3 showed 99.1% to 100% identity
with the reference isolate PJ99-162 (AB107963); sequence
polymorphism was shown only in isolate clones LMS-29cd and
LMS-26ab with one and four base substitutions, respectively.
Moreover, intra-subtype sequence polymorphism may naturally
reflect the potential existence of subgroups within the same
subtype as recently suggested [50].
The phylogenetic tree revealed three well-defined clades that
identified and classified the representative isolates into three
different subtypes. Overall, the clades identified in this analysis
are in agreement with those defined in previous studies [7,11].
The rooted neighbor-joining (NJ) tree indicated that ST1 and
ST2 share a common ancestor. The tree also revealed that
ST3, ST4 and ST8, as well as ST6 and ST9 are closely related.
Previous studies have also noted the close relationship
between ST1 and ST2, as well as ST3 and ST4 [16,51].
Blastocystis ST1 was the highest prevalent (51.1%, 23/45)
among the examined outpatients, followed by ST2 (24.4%,
11/45) and ST3 (17.8%, 8/45). In a recent study, the
distribution of Blastocystis subtypes was investigated in three
African countries by Alfellni et al. [52] including Libya, Nigeria
and Liberia. Four subtypes were detected in the Libyan
population with ST1 (50.0%, 19/38) as the highest prevalent
followed by ST3 (39.5%, 15/38), ST2 (7.9%, 3/38) and ST7
(2.6%, 1/38). However, in this study, ST7 was not found which
could be due to the differences in primers and subtyping
method used by Alfellni et al. [52]. Distribution of Blastocystis
sp. subtypes in the human population of several countries is
listed in Table 4. It is shown that ST1 is widely reported in all
listed countries and predominant in several countries including
Libya, Thailand, Nigeria, Brazil and Iran. ST3 was predominant
in most of the listed countries. ST2 occurred as the third most
common except in Ireland and Tanzania. ST4 was the
predominant subtype in Spain and commonly found in
Denmark and UK. ST6, ST7, ST8 and ST9 were occasionally
detected in several countries. These data show that the
subtypes present in humans may vary with the geographic
distribution of Blastocystis sp. and reflect differences in
epidemiological characteristics, study population, reservoirs
and dynamics of transmission [13,15].
ST3 was predominant in humans [2,12,54,55] but relatively
low prevalent in different animals [16,19,41,53]. It was
suggested to be the only subtype of human origin and has
human-to-human transmission [2,54,55]. The other remaining
subtypes were likely of zoonotic origin [2,7,55,56]. Additionally,
ST1 and ST2 support the low host specificity found in a wide
range of animals including monkeys, chickens, cattle, pigs,
dogs and non-human primates [7,57,58]. In the current study,
ST1 and ST2 were found to be common in Libyan outpatients
coming from varied family backgrounds, such as agricultural,
animal husbandry, private and government workers. Most
families lived nearby Sebha city and owned animal farms
surrounding their houses. Therefore, the occurrence of
zoonotic transmission of Blastocystis in this population is a
possibility. However, in a recent study, Blastocystis ST1 and
ST3 but not ST2 were isolated from camels and goats in Libya
at relatively low percentages (ST1 7%, ST3 9%) [19]. The
same subtypes were previously found to be dominant (ST1
50%, ST3 39.5%) in Libyan population [52] suggesting that
zoonotic transmission is unlikely to occur [19]. However, the
animals with which the Libyan population has the most contact
are sheep and these have not been sampled in Libya [19].
Therefore, more studies on Blastocystis in animals in Libya
particularly those in close contact with humans are required.
The majority (93.3%, 42/45) had a single subtype infection
whereas 6.7% (3/45) had mixed infections with two concurrent
subtypes. The presence of multiple subtypes may indicate the
concurrent existence of different sources of infection or one
source containing multiple subtypes. Besides, the existence of
mixed infections observed in this study may be underestimated
since only three to four clones were sequenced per sample.
Recently, sequencing up to ten clones [41], enabled three
different subtypes in a primate isolate to be identified.
Furthermore, utilizing in vitro culture prior to PCR can also be a
source of underestimation of mixed infections, as this method
may favour the preferential growth of a certain subtype over the
others [9,59]. Hence, genotyping of Blastocystis DNA obtained
directly from stools may be more accurate for identifying mixed
infections if PCR conditions are optimal [2]. In general, the
prevalence of mixed infections in our study is similar to that
described in different countries, which ranged between 2.6%
and 14.3% [13,14,29,60,61]. In the latter conditions, mixed
infections were expected with several concurrent subtypes
such as ST1 and ST3, ST1 and ST2, or ST2 and ST3.
The present study showed differences in the occurrence of
Blastocystis ST1 infection between male and female
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Table 4. Subtype distribution of human Blastocystis sp. isolates from different countries.
Country (Ref) Participant (no. of sample) Subtype distribution
  ST1 ST2 ST3 ST4 ST5 ST6 ST7 ST8 ST9 Unk/MSI
Libya* Symptomatic (29) 15 5 8 - - - - - - 1
 Asymptomatic (16) 8 6 - - - - - - - 2
Libya [52] Outpatient (38) 19 3 15 - - - 1 - - -
Australia [72] Patients (91) 28 5 40 12 - 3 1 2 - -
Bangladesh [55] Symptomatic (11) 1 - 10 - - - - - - -
 Asymptomatic (15) 1 - 14 - - - - - - -
Brazil [73] Indigenous community (66) 27 21 11 - - - - - - 7
China [23] Symptomatic (16) 9 - 2 - - - - - - 5
 Asymptomatic (19) 4 - 12 - - - 2 - - 1
China [60] Rural community (78) 16 1 55 1 - - - - - 5
Denmark [29] General population (24) 2 3 6 9 - - - - 1 3
 Patients (92) 19 19 15 11 - - 5 - - 23
Denmark [74] Patients (99) 20 15 39 16 - 1 - 1 - 7
Egypt [67] Symptomatic (28) 8 - 16 - - 4 - - - -
 Asymptomatic (16) - - 8 - - 4 4 - - -
Egypt [75] IBS patients (51) 15 - 22 - - 8 - - - 6
 Control (49) - - 17 - - 15 13 - - 4
France [13] Symptomatic (25) 4 4 13 2 - - - - - 2
 Asymptomatic (15) 4 - 7 2 - - 1 - - 1
France [76] HM patients (15) - - 3 10 - 1 1 - - -
 Control (12) 1 1 1 7 - - 2 - - -
Germany [55] Patient (12) 3 2 5 2 - - - - - -
Greece [77] Symptomatic (19) - - 18 1 - - - - - -
 Asymptomatic (32) 7 5 14 - - 1 5 - - -
Iran [78] Patient (45) 20 4 16 - - 2 3 - - -
Ireland [79] Healthy persons (14) 1 6 4 3 - - - - - -
Italy [14] Symptomatic (34) 3 7 16 6 - - 1 1 - -
Japan [55] Patient (50) 4 0 26 2 0 11 5 0 2 0
Lebanon [80] Symptomatic (19) 10 5 3 - - - - - - -
 Asymptomatic (18) 1 7 9 1 - - - - - -
Liberia [52] Schoolchildren (30) 7 7 8 3 - - - - - 5
Malaysia [81] HIV patient (20) 3 1 11 5 - - - - - -
 Cancer patient (20) 2 1 9 6 - - - - - 2
Mexico [30] IBS patients (14) 2 1 2 - - - - - - 9
 Control (6) - - 3 - - - - - - 3
Nepal [10] Symptomatic (20) 4 4 12 - - - - - - -
Nigeria [52] Patient (23) 10 - 9 3 - - - - - 1
Pakistan [55] Symptomatic (10) 2 - 7 - - 1 - - - -
Pakistan [82] IBS patients (123) 75 6 23 6 3 3 5 - - 2
 Control (56) 12 4 26 2 4 3 5 - - -
Singapore [54] Patient (9) 2 - 7 - - - - - - -
Spain [22] Symptomatic (51) 1 2 - 48 - - - - - -
Sweden [83] Patient (63) 10 9 30 13 - - 1 - - -
Thailand [84] Army personnel (153) 138 - 7 - - - 2 - - 6
Thailand [85] Schoolchildren (68) 53 15 - - - - - - - -
Tanzania [86] Healthy persons (6) 1 3 2 - - - - - - -
Turkey [12] Symptomatic (69) 6 9 53 1 - - - - - -
 Asymptomatic (18) 2 3 13 - - - - - - -
UK [47] Patient (54) 3 9 22 17 - - - 3 - -
UK [52] IBS patients (136) 14 10 56 51 - 1 1 3 - -
 Control (135) 20 16 58 34 2 - 3 2 - -
USA [65] Symptomatic (9) 1 - 6 - - - - - - 2
Total sample 2141 618 219 789 274 9 58 61 12 3 97
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outpatients. This finding contradicts previous studies which
found no significant associations between gender and subtypes
of Blastocystis sp. [12,25,62]. Differences in the relative
proportions of subtypes between the genders could indicate
distinct ways of transmission or different exposures to the
sources of transmission [60]. As our study involved a small
sample size, further identification in a greater number of
subtypes is needed to confirm the association between
Blastocystis subtypes against the demographic and
socioeconomic characteristics of the outpatients. Our findings
showed that ST2 was significantly associated with low level of
education. It is well documented that the level of education can
influence the prevalence of parasitic infections including
Blastocystis sp. [36,63], and that hygienic conditions and
sanitary practices would be better in those with a higher level of
education.
The pathogenic potential of Blastocystis remains uncertain
because of the conflicting reports about clinical symptoms
caused by Blastocystis infection. Recently, it has been
generally assumed that certain subtypes may contribute to the
pathogenicity. In this study, all patients with ST3 presented with
gastrointestinal symptoms and had no other pathogenic
parasite infections. Fisher’s exact test showed that ST3 was
significantly related with the presence of diarrhoea. This finding
is in agreement with previous reports which stated that ST3
was predominant in patients with chronic gastrointestinal illness
in several countries including Malaysia [64], Singapore [54], the
USA [65] and Egypt [61]. ST3 infection was significantly higher
in symptomatic Thai patients (especially diarrhoea) as
compared to asymptomatic individuals [66]. In our study,
despite the suggestion of an association between ST3 and its
possible pathogenicity, our sample size was too small and
investigation on the presence of virus or bacteria was not
conducted.
In the current study, ST1 infection is more common among
symptomatic individuals compared to asymptomatic individuals.
However, no significant association was found between
Blastocystis ST1 infection and gastrointestinal symptoms. One
symptomatic patient (L18-9/F) with ST1 (isolate LFS-4) had
Giardia intestinalis co-infection, which could have been the
main cause of intestinal symptoms. Previous studies have
demonstrated that ST1 was associated with elevated
pathogenicity [21,23,67]. However, a report by Tan et al [64]
indicated otherwise; ST1 was only detected among the isolates
from asymptomatic groups. As for ST2, 6 and 5 isolates were
detected in asymptomatic and symptomatic patients,
respectively. An asymptomatic patient (L5-27/M) was found to
be co-infected with Cryptosporidium species. On the other
hand, ST2 has been suggested to be a non-pathogenic
genotype of Blastocystis [21,25] although several reports found
that ST2 was associated with symptomatic infections [29,68].
The correlation between Blastocystis incidence and symptoms
and the lack of correlation between specific subtypes and
symptoms may be due to the fact that the clinical outcome of
Blastocystis infection is multifactorial, involving host factors
(genetics, immunity and age) or parasite factors (genotype,
virulence and zoonotic potential) or a combination of the two
[69]. As a limitation, this study may a selection bias as the
samples were collected from patients presented to the Sebha
Central Laboratory. Moreover, the patients were not keen to
bring subsequent stool sample, and a single stool sample
collection could influence the detection rate of Blastocystis and
other intestinal parasites. For optimum parasite detection, at
least three specimens collected on three successive days is
recommended.
In conclusion, this is the first molecular study on the
associated factors of human Blastocystis infection in Libya. The
genetic polymorphism of SSU rDNA among the different
Blastocystis isolates found in this study showed that these
organisms are genetically highly divergent. Among the three
identified subtypes, ST1 was predominant and its infection was
significantly associated with female gender and low level of
education. Although all three subtypes were detected in
symptomatic outpatients, ST3 infection was found to be
significantly associated with gastrointestinal symptoms,
indicating that the pathogenic potential of Blastocystis sp. might
be subtype-related. Despite the suggestion of an association
between ST3 and its possible pathogenicity, our sample size
was too small and detection of virus or bacteria was not
conducted, and thus further studies are needed to confirm this
issue.
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